Additionally, the olfactory bulbectomy-induced depression model exhibited increased CD11b (macrophage/microglia marker), GFAP (Glial fibrillary acidic protein, astrocyte marker) and IL-1β levels in the amygdala, but the spinal nerve ligation-induced neuropathic pain alone or combined with olfactory bulbectomy does not change the expression of these cytokines (Burke et al., 2013), demonstrating that although pain and depression have several similarities, they may also involve different pathways. The gene discussed is GFAP; the disease is depressive disorder.